May. 10 at 6:53 AM
$CMPS
Feel free to shun me off the boards, but just here to chime in for support of psilocybin candidates as a whole 🤗:
$TRUFF +
$FLHLF are still have the only naturally derived psilocybin candidate, with 50-70 clinical sites utilizing it, as well as multiple phase 2 studies running concurrently across 14+ indications.
They are no Compass, and I want Compass to succeed ENORMOUSLY, but when ppl start understanding how truly hard it is to standardize and get approval for treatment from botanical sources, they’ll see the light. Also blowing past multiple phase 2 studies may help in this regard.
Their extraction patents are gold standard and it’ll be hard for any company to match their reputation in the world of botanically grown.
Ultimately, it’s a whole lot cheaper to grow in the field than in the lab, and they’re currently building an 85K sqr foot facility for shroom harvest 🍄
My bet is on Compass for blaring reasons, but don’t sleep on
$TRUFF &
$FLHLF 🚀
